ABDXF (Abingdon Health) Operating Margin %: -53.88% (As of Dec. 2025)


ABDXF Abingdon Health PLC ABDXF
49 GF Score
Price $0.15
GF Value $0.21
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Abingdon Health Operating Margin %?

Abingdon Health ABDXF +8.93% 49 Operating Margin % is -53.88% as of Dec. 2025. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.21 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Abingdon Health ranks worse than 72.55% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Abingdon Health's Operating Income for the six months ended in Dec. 2025 was $-3.06 Mil. Abingdon Health's Revenue for the six months ended in Dec. 2025 was $5.67 Mil. Therefore, Abingdon Health's Operating Margin % for the quarter that ended in Dec. 2025 was -53.88%.

The historical rank and industry rank for Abingdon Health's Operating Margin % or its related term are showing as below:

ABDXF' s Operating Margin % Range Over the Past 10 Years
Min: -423.7   Med: -46.24   Max: 4.15
Current: -32.92


ABDXF's Operating Margin % is ranked worse than
72.55% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195 vs ABDXF: -32.92

Abingdon Health's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Abingdon Health's Operating Income for the six months ended in Dec. 2025 was $-3.06 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-4.23 Mil.

Warning Sign:

Abingdon Health PLC has never been profitable in the past 3 years. It lost money every year.


Abingdon Health  (OTCPK:ABDXF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Abingdon Health Operating Margin % Related Terms


Abingdon Health Operating Margin % Historical Data

* Premium members only.

The historical data trend for Abingdon Health's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abingdon Health Operating Margin % Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Operating Margin %
Get a 7-Day Free Trial -46.24 -423.75 -89.27 -22.38 -41.63

Abingdon Health Semi-Annual Data
Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.40 9.98 -85.35 -16.27 -53.88

ABDXF vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, Abingdon Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Operating Margin % falls into.


ABDXF
49GF Score
Abingdon Health PLC ABDXF
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abingdon Health Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Abingdon Health's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as

Operating Margin %=Operating Income (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=-4.761 / 11.437
=-41.63 %

Abingdon Health's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-3.056 / 5.672
=-53.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -53.88% mean?
Abingdon Health (ABDXF) has a Operating Margin % of -53.88% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Abingdon Health and its competitors. According to the industry distribution chart, Abingdon Health ranks #148 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 72.5%.
Is Abingdon Health's Operating Margin % too high?
Abingdon Health's current Operating Margin % is -53.88%. Based on the distribution chart, Abingdon Health ranks #148 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Abingdon Health ranks #148 out of 204 companies for Operating Margin %. This places Abingdon Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Abingdon Health and its competitors. Abingdon Health's current Operating Margin % is -53.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.21, compared to a current price of $0.15 — trading 27.4% below its estimated fair value. The current Operating Margin % is -53.88%. Abingdon Health's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Operating Margin % is -53.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abingdon Health (ABDXF) Overvalued in 2026?

Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued. The current stock price of $0.15 is trading 27.4% below its estimated GF Value™ of $0.21. GuruFocus considers Abingdon Health to be Modestly Undervalued.

Key valuation signals for ABDXF:

  • Operating Margin %: -53.88%
  • GF Value™: $0.21 vs. price of $0.15 (27.4% below fair value)
  • GF Score™: 49/100 with 9 warning signs

No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abingdon Health Business Description

Other Exchanges ABDX:UK
Address York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score

Get the complete analysis for ABDXF

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.21
GF Value